Skip to NavigationSkip to content

AZ appoints Genentech’s Sean Bohen as chief medical officer

Published on: 25/08/15

AstraZeneca has appointed Dr Sean Bohen as executive vice president of global medicines development and chief medical officer.

Dr Bohen will be responsible for the progress of AstraZeneca’s portfolio of small molecules and biologics investigational medicines through late-stage development to regulatory approval. Bohen will join the company on 15 September.

As chief medical officer, he will be responsible for patient safety across the entire AstraZeneca and Medimmune portfolio.

Bohen joins AstraZeneca from Genentech where he was instrumental in bringing a large number of new medicines to patients, in particular for cancer, and led activities to incorporate diagnostics into clinical programmes.

At Genetech Bohen was most recently senior vice president of early development. He oversaw preclinical and clinical development programmes across all therapy areas, including oncology, respiratory and autoimmune diseases, to deliver trial-ready drug candidates to late-stage development

Prior to joining Genentech, Bohen was a clinical instructor in oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the National Cancer Institute.

AstraZeneca chief executive Pascal Soriot says: “I’m delighted to welcome Sean to AstraZeneca at a very exciting time for our company. Our continued strategic investment in science is driving momentum across all therapy areas. Sean is a tremendous scientist and an accomplished drug developer. His impressive expertise in key areas of our exciting pipeline, including oncology and immunology, will further strengthen and accelerate the delivery of new medicines for patients. His extensive diagnostics experience will also reinforce our efforts in precision medicine.”

Bohen replaces Briggs Morrison, who left AstraZeneca in June to become chief executive of Syndax Pharmaceuticals, a small biotech firm based in Waltham, Massachusetts. 

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches